Third, despite adjustment for potential confounders (e.g. age, sex, country, baseline CD4+ T-cell count and excluding participants with chronic hepatitis B or tuberculosis), we cannot rule out residual confounding effects on microRNA levels. The gene discussed is CD4; the disease is chronic hepatitis B virus infection.